{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:14:16Z","timestamp":1778591656543,"version":"3.51.4"},"reference-count":19,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The genotypic variability of the SARS-CoV-2 virus is extremely high, and the emergence of new strains raises concerns about their possible high virulence and ability to bypass responses of the body\u2019s immune system induced by previous infection or vaccination. Therefore, one of the main tasks is to study the pathogenesis of various variants of the virus using experimental animal biomodels of SARS-CoV-2 to quickly find methods and approaches to fighting new viruses. The study was performed on humanized mice of the C57BL\/6-Tgtn line. Mice were infected intranasally at different doses with three variants of the SARS-CoV-2 virus. We showed that humanized hACE2 mice, when infected with all three variants of the SARS-CoV-2 virus, showed typical pathological changes in lung consistency comparable to those found in COVID-19 in humans. At a dose of 4 log plaque-forming unit (PFU), all variants showed 100% mortality. In a comparative assessment of different variants of the SARS-CoV-2 virus in hACE2 humanized mouse model, it was found that the Delta variant leads to more severe damage compared to Wuhan or Omicron.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1134\/s1607672925601787","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:47:09Z","timestamp":1770227229000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathomorphological Features of Lung Damage Caused by Infection with Various Variants of SARS-CoV-2 in Humanized Model Animals"],"prefix":"10.1134","volume":"526","author":[{"given":"A. S.","family":"Chernov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Kazakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. S.","family":"Gogleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Mescheryakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Kudriaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Bogachuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Smirnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. B.","family":"Telegin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Belogurov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Gabibov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"7790_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41256-020-00135-6","volume":"5","author":"H. Zhu","year":"2020","unstructured":"Zhu, H., Wei, L., and Niu, P., The novel coronavirus outbreak in Wuhan, China, Global Health Res. Policy, 2020, vol. 5, p. 6.","journal-title":"Global Health Res. Policy"},{"key":"7790_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s11658-022-00352-6","volume":"27","author":"M. Saberiyan","year":"2022","unstructured":"Saberiyan, M., Karimi, E., Khademi, Z., et al., SARS-CoV-2: phenotype, genotype, and characterization of different variants, Cell. Mol. Biol. Lett., 2022, vol. 27, no. 1, p. 50.","journal-title":"Cell. Mol. Biol. Lett."},{"key":"7790_CR3","unstructured":"Aleem, A., Akbar Samad, A.B., and Vaqar, S., Emerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19), Treasure Island, FL: StatPearls Publishing, 2023. PMID: 34033342."},{"key":"7790_CR4","doi-asserted-by":"crossref","unstructured":"Liu, Y., Liu, J., Johnson, B.A., et al., Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant, bioRxiv, 2021, p. 2021.08.12.456173.","DOI":"10.1101\/2021.08.12.456173"},{"key":"7790_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","volume":"602","author":"A. Saito","year":"2022","unstructured":"Saito, A., Irie, T., Suzuki, R., et al., Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation, Nature, 2022, vol. 602, pp. 300\u2013306.","journal-title":"Nature"},{"key":"7790_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00011-022-01555-5","volume":"71","author":"B. Biswas","year":"2022","unstructured":"Biswas, B., Chattopadhyay, S., Hazra, S., et al., COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines, Inflamm. Res., 2022, vol. 71, pp. 377\u2013396.","journal-title":"Inflamm. Res."},{"key":"7790_CR7","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/jmv.27561","volume":"94","author":"R.K. Mohapatra","year":"2022","unstructured":"Mohapatra, R.K., Sarangi, A.K., Kandi, V., et al., Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario, J. Med. Virol., 2022, vol. 94, no. 5, pp. 1780\u20131783.","journal-title":"J. Med. Virol."},{"key":"7790_CR8","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.15829\/1728-8800-2022-3228","volume":"21","author":"V. Vechorko","year":"2022","unstructured":"Vechorko, V., Averkov, O., and Zimin, A., New SARS-CoV-2 Omicron variant - clinical picture, treatment, prevention (literature review), Cardiovasc. Ther. Prev., 2022, vol. 21, p. 3228. https:\/\/doi.org\/10.15829\/1728-8800-2022-3228","journal-title":"Cardiovasc. Ther. Prev."},{"key":"7790_CR9","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J. Netland","year":"2008","unstructured":"Netland, J., Meyerholz, D.K., and Moore, S., Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2, J. Virol., 2008, vol. 82, no.\u00a015, pp. 7264\u20137275.","journal-title":"J. Virol."},{"key":"7790_CR10","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1073\/pnas.1517719113","volume":"113","author":"V.D. Menachery","year":"2016","unstructured":"Menachery, V.D., Yount, B.L.Jr., Sims, A.C., et al., SARS-like WIV1-CoV poised for human emergence, Proc. Natl. Acad. Sci. U. S. A., 2016, vol. 113, no. 11, pp.\u00a03048\u20133053.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"7790_CR11","first-page":"450","volume":"57","author":"X.H. Yang","year":"2007","unstructured":"Yang, X.H., Deng, W., Tong, Z., et al., Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection, Comp. Med., 2007, vol. 57, no. 5, pp. 450\u2013459.","journal-title":"Comp. Med."},{"key":"7790_CR12","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1128\/JVI.02272-08","volume":"83","author":"N. Yoshikawa","year":"2009","unstructured":"Yoshikawa, N., Yoshikawa, T., and Hill, T., Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2, J. Virol., 2009, vol. 83, no. 11, pp. 5451\u20135465.","journal-title":"J. Virol."},{"key":"7790_CR13","doi-asserted-by":"crossref","unstructured":"Asaka, M.N., Utsumi, D., Kamada, H., et al., Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice, JCI Insight, 2021, vol.\u00a06, p. e152529.","DOI":"10.1172\/jci.insight.152529"},{"key":"7790_CR14","doi-asserted-by":"publisher","first-page":"s23","DOI":"10.1134\/s1068162022060255","volume":"48","author":"D.S. Tretiakova","year":"2022","unstructured":"Tretiakova, D.S., Alekseeva, A.S., Onishchenko, N.R., Boldyrev, I.A., Egorova, N.S., Vasina, D.V., Gushchin, V.A., Chernov, A.S., Telegin, G.B., Kazakov, V.A., Plokhikh, K.S., Konovalova, M.V., Svirshchevskaya, E.V., and Vodovozova, E.L., Proof-of-concept study of\u00a0liposomes with a set of SARS-CoV-2 viral peptidic T-cell epitopes as a vaccine, Russ. J. Bioorg. Chem., 2022, vol. 48, no. s1, pp. s23\u2013s37. https:\/\/doi.org\/10.1134\/s1068162022060255","journal-title":"Russ. J. Bioorg. Chem."},{"key":"7790_CR15","first-page":"3","volume":"65","author":"S.Ya. Loginova","year":"2020","unstructured":"Loginova, S.Ya., Shchukina, V.N., Savenko, S.V., et\u00a0al., Antiviral activity of Kagocel\u00ae in vitro against virus SARS-CoV-2, Antibiot. Chemother., 2020, vol. 65, pp. 3\u20134.","journal-title":"Antibiot. Chemother."},{"key":"7790_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00011-022-01568-0","volume":"71","author":"A.S. Chernov","year":"2022","unstructured":"Chernov, A.S., Minakov, A.A., Kazakov, V.A., et al., A\u00a0new mouse unilateral model of diffuse alveolar damage of the lung, Inflamm. Res., 2022, vol. 71, no. 5, pp.\u00a0627\u2013639.","journal-title":"Inflamm. Res."},{"key":"7790_CR17","doi-asserted-by":"crossref","unstructured":"Francis, M.E., Goncin, U., Kroeker, A., et al., SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney, PLoS Pathog, 2021, vol. 17, no. 7, p. e1009705.","DOI":"10.1371\/journal.ppat.1009705"},{"key":"7790_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/v15030748","volume":"15","author":"A. Handley","year":"2023","unstructured":"Handley, A., Ryan, K.A., Davies, E.R., Bewley, K.R., Carnell, O.T., Challis, A., Coombes, N.S., Fotheringham, S.A., Gooch, K.E., Charlton, M., Harris, D.J., Kennard, Ch., Ngabo, D., Weldon, T.M., Salguero, F.J., Funnell, S.G.P., and Hall, Yp., SARS-CoV-2 disease severity in the golden Syrian hamster model of infection is related to the volume of intranasal inoculum, Viruses, 2023, vol. 15, no. 3, p. 748. https:\/\/doi.org\/10.3390\/v15030748","journal-title":"Viruses"},{"key":"7790_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.eimc.2022.11.003","volume":"42","author":"E. Varea-Jim\u00e9nez","year":"2022","unstructured":"Varea-Jim\u00e9nez, E., Cano, E.A., Vega-Piris, L., S\u00e1nchez, E.V.M., Mazagatos, C., Rodr\u00edguez-Alarc\u00f3n,\u00a0L.G.S.M., Casas, I., Sierra Moros, M.J., Iglesias-Caballero, M., Vazquez-Mor\u00f3n, S., Larrauri, A., Monge, S., the Working Group for the Surveillance and Control of COVID-19 in Spain, and RELECOV, Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination, Enferm. Infecc. Microbiol. Clin., 2022, vol.\u00a042, no. 4, pp. 187\u2013194.","journal-title":"Enferm. Infecc. Microbiol. Clin."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925601787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925601787","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925601787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:49:16Z","timestamp":1778590156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925601787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7790"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925601787","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments and manipulations with animals were approved by the Institute Committee for the Care and Use of Laboratory Animals of the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IACUC no. 746\/20 dated February 20, 2021).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}